Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
16.17
0.00 (0.00%)
At close: Oct 29, 2025, 4:00 PM EDT
16.49
+0.32 (1.98%)
After-hours: Oct 29, 2025, 7:53 PM EDT
Benitec Biopharma Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
19
Market Cap
424.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | - | - | - |
| Jun 30, 2024 | - | - | - |
| Jun 30, 2023 | 75.00K | 2.00K | 2.74% |
| Jun 30, 2022 | 73.00K | 14.00K | 23.73% |
| Jun 30, 2021 | 59.00K | -43.00K | -42.16% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
BNTC News
- 5 weeks ago - Benitec Biopharma Releases Full Year 2025 Financial Results and Provides Operational Update - GlobeNewsWire
- 7 months ago - Benitec Biopharma: An Under-The-Radar And Undervalued Gene Therapy Developer - Seeking Alpha
- 7 months ago - Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering - GlobeNewsWire
- 9 months ago - Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update - GlobeNewsWire
- 1 year ago - Benitec Biopharma to Participate in Upcoming Investor Conferences in December - GlobeNewsWire
- 1 year ago - Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update - GlobeNewsWire
- 1 year ago - Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference - GlobeNewsWire
- 1 year ago - Benitec Biopharma: OPMD Program Continues To Advance With Catalysts - Seeking Alpha